🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1222.6.064 Arthur F. Gelb Medical Corporation, Lakewood
Start Date
2007-05
Trial ID
NCT00467740
Treatments Being Tested
To investigate safety, tolerability, pharmacokinetics and pharmacodynamics ...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT02259959
The primary objective of the trial is to determine the effect of BI 17444Cl...
Status
Completed
Location
1222.26.32008 Boehringer Ingelheim Investigational Site
Start Date
2009-02
Trial ID
NCT00846768
Treatments Being Tested
The primary objective of this study is to assess the long-term efficacy and...
Status
Completed
Location
1222.14.5004 Boehringer Ingelheim Investigational Site
Start Date
2009-01
Trial ID
NCT00796653
Treatments Being Tested
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1237.9.00152 Boehringer Ingelheim Investigational Site
Start Date
2008-07
Trial ID
NCT00720499
Treatments Being Tested
Study to investigate safety and tolerability of single, inhaled doses (2.5 ...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT02259946
Treatments Being Tested
To investigate safety, tolerability, and pharmacokinetics (PK) of single i....
Status
Terminated
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT02172131
Treatments Being Tested
The study is intended to characterize the lung function profile of BI1744 i...
Status
Completed
Location
1222.25.25009 Boehringer Ingelheim Investigational Site
Start Date
2009-06
Trial ID
NCT00932646
Treatments Being Tested
The purpose of this study is to compare the systemic exposure to BI 1744 BS...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT02231177
Treatments Being Tested
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1237.4.0118 Boehringer Ingelheim Investigational Site
Start Date
2008-06
Trial ID
NCT00696020
Treatments Being Tested